Owner Celldex Therapeutics, Inc.

Inventors Treml, John; Keler, Tibor; Deo, Yashwant M.

Agent Shelston IP

Pub. Number AU-B-2001261383

PCT Pub. Number WO01/85798

Priority 60230739 07.09.00 US; 60203126 08.05.00 US

Filing date 8 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 21 October 2004

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 035/00 Antineoplastic agents

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 039/12 Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 039/02 Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 039/00 Medicinal preparations containing antigens or antibodies

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 033/577 Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

G01N 033/569 Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 016/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A01K 067/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C12N 005/20 Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

A61P 037/00 Drugs for immunological or allergic disorders